BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30243785)

  • 1. Tendon thickening in dialysis-related joint arthritis is due to amyloid deposits at the surface of the tendon.
    Sigaux J; Abdelkefi I; Bardin T; Laredo JD; Ea HK; UreñaTorres P; Cohen-Solal M
    Joint Bone Spine; 2019 Mar; 86(2):233-238. PubMed ID: 30243785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of magnetic resonance imaging of the wrist for the early diagnosis of dialysis-related amyloidosis].
    Mochizuki T; Mitobe M; Mifune N; Takahashi M
    Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):14-20. PubMed ID: 10077983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis-related amyloidosis: Is it still relevant?
    Kaneko S; Yamagata K
    Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G; Argilés A
    J Am Soc Nephrol; 1996 May; 7(5):798-804. PubMed ID: 8738817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid arthropathy of the hip joint: MR demonstration of presumed amyloid lesions in 152 patients with long-term hemodialysis.
    Otake S; Tsuruta Y; Yamana D; Mizutani H; Ohba S
    Eur Radiol; 1998; 8(8):1352-6. PubMed ID: 9853212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of dialysis-related amyloidosis of the shoulder and hip.
    Escobedo EM; Hunter JC; Zink-Brody GC; Andress DL
    Skeletal Radiol; 1996 Jan; 25(1):41-8. PubMed ID: 8717118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin amyloidosis in chronic dialysis patients: a case report and review of the literature.
    Farrell J; Bastani B
    J Am Soc Nephrol; 1997 Mar; 8(3):509-14. PubMed ID: 9071720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonographic features of dialysis-related amyloidosis of the shoulder.
    Sommer R; Valen GJ; Ori Y; Weinstein T; Katz M; Hendel D; Korzets A
    J Ultrasound Med; 2000 Nov; 19(11):765-70. PubMed ID: 11065265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
    Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR
    Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis.
    Montagna G; Cazzulani B; Obici L; Uggetti C; Giorgetti S; Porcari R; Ruggiero R; Mangione PP; Brambilla M; Lucchetti J; Guiso G; Gobbi M; Merlini G; Salmona M; Stoppini M; Villa G; Bellotti V
    Amyloid; 2013 Sep; 20(3):173-8. PubMed ID: 23734692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-microglobulin and renal bone disease.
    Wada T; Miyata T; Sakai H; Kurokawa K
    Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M; Miyata T; Kurokawa K
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
    J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
    Floege J; Schäffer J; Koch KM
    Nephrol Dial Transplant; 2001; 16 Suppl 4():12-6. PubMed ID: 11402091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of magnetic resonance in hemodialysis patients with amyloid shoulder arthropathy].
    Della Sala SW; Centonze M; Ghobert AD; Andreotti C; Bianchini G; Dalla Palma F
    Radiol Med; 1998 Oct; 96(4):300-9. PubMed ID: 9972207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
    Miyata T; Inagi R; Kurokawa K
    Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients.
    Takayama F; Miyazaki S; Morita T; Hirasawa Y; Niwa T
    Kidney Int Suppl; 2001 Feb; 78():S172-6. PubMed ID: 11169005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis.
    Kazama JJ; Maruyama H; Gejyo F
    Nephrol Dial Transplant; 2001; 16 Suppl 4():31-5. PubMed ID: 11402095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis arthropathy: a clinical, biochemical, radiological and histological study of 36 patients.
    Sethi D; Morgan TC; Brown EA; Cary NR; Erhardt CC; Pazianas M; Maini RN; Woodrow DF; Gower PE
    Q J Med; 1990 Oct; 77(282):1061-82. PubMed ID: 2267282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.